What is H&M HENNES & MAURITZ AB (HMRZF)'s fair-value range?

EvidInvest does not publish a fair-value range for H&M HENNES & MAURITZ AB (HMRZF). Financials are filed in SEK; our prices are in USD, so these methods need a conversion we do not yet publish. The filed statements, the filing citations and the growth history are all available at https://evidinvest.com/valuation/HMRZF. Not investment advice.

How is H&M HENNES & MAURITZ AB (HMRZF)'s fair value calculated?

H&M HENNES & MAURITZ AB (HMRZF)'s fair value is computed with several independent methods — a discounted cash flow (DCF) model, the Graham number, earnings power value (EPV), and valuation multiples (PE, EV/EBITDA, P/S, P/B) benchmarked against its industry — using data from SEC filings.

What is H&M HENNES & MAURITZ AB (HMRZF)'s PE ratio versus its industry?

EvidInvest shows H&M HENNES & MAURITZ AB (HMRZF)'s current and historical PE ratio alongside its sector and industry averages, so you can see whether the stock trades at a premium or discount to peers. Full breakdown at https://evidinvest.com/valuation/HMRZF.

Fair value · H&M HENNES & MAURITZ AB (HMRZF) · updated 2026-09-21 · from annual report FY2025

H&M HENNES & MAURITZ AB trades at $18.56. We are not reading assumptions out of that price: financials are filed in SEK; our prices are in USD, so these methods need a conversion we do not yet publish.

Everything below is unaffected: the filed statements, the filing they came from, and HMRZF’s growth history are all as reported.

Check another stock

The filing behind these numbers

H&M HENNES & MAURITZ AB

Revenue: SEK 228.3B
Diluted EPS: SEK 7.58
Free cash flow: SEK 20.4B; operating cash flow − capital expenditure
Diluted shares: 1.60B; weighted average

annual report FY2025 · fiscal year ended 2025-11-30 · filed 2025-11-30

Trailing-twelve-month EPS also uses the quarterly 6-Ks through Q2 FY2026 (filed 2026-05-31).

Open the annual report list on sec.govCIK 1396282

Valuation tool: build your own HMRZF range

Fair Value Summary

Daily Price — HMRZF

$16.80 -13.8% (1Y)

Your range0 of 7 methods

At least two methods need a usable value to draw a range with these inputs.

Range with preset inputs

No preset range for this company yet.

The two ranges are identical because every input sits on a preset.

We don’t tell you what HMRZF is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has HMRZF’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.

Discounted cash flow

N/A

Financials are filed in SEK; our prices are in USD, so these methods need a conversion we do not yet publish.

Preset inputs — revenue-driven DCF from the latest filing

Implied by today’s price

Financials are filed in SEK; our prices are in USD, so these methods need a conversion we do not yet publish.

Not solvable from the price — Financials are filed in SEK; our prices are in USD, so these methods need a conversion we do not yet publish. Showing preset inputs.

This method has no key input to read out of the price. The others below do, and you set them yourself: the growth matrix shows what HMRZF has actually filed, and the AI chat will reason it through with you.

Your inputs

Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.

Stage-1 growth29.9%

Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.

-20.0%60.0%

Stage-1 years5 yrs

How long stage-1 growth lasts.

1 yrs10 yrs

Stage-2 growth8.2%

Slower growth after stage 1, before the terminal phase.

-20.0%30.0%

Stage-2 years5 yrs

0 yrs10 yrs

Terminal growth2.5%

Growth forever after the two stages. Above ~3% is rarely justified.

0.0%5.0%

Discount rate (WACC)5.60%

The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.

3.00%15.00%

Net debt ($M)Debt minus cash, from the balance sheet. Subtracted from enterprise value.

Starting FCF ($M)Latest free cash flow from the filing (operating cash flow minus capex).

Shares (M)Diluted shares, from the filing.

Year by year (two-stage model, $M)

PV explicit $508,348M · PV terminal $2,149,845M · EV $2,658,193M · equity $2,601,554M

Year	Stage	FCF	Present value
1	Stage 1	$26,553M	$25,145M
2	Stage 1	$34,492M	$30,931M
3	Stage 1	$44,805M	$38,049M
4	Stage 1	$58,202M	$46,804M
5	Stage 1	$75,605M	$57,574M
6	Stage 2	$81,804M	$58,992M
7	Stage 2	$88,512M	$60,444M
8	Stage 2	$95,770M	$61,932M
9	Stage 2	$103,623M	$63,457M
10	Stage 2	$112,120M	$65,020M

Inputs from the filing

Financials are filed in SEK; our prices are in USD, so these methods need a conversion we do not yet publish.

Free cash flow: SEK 23.5B; sum of the last four quarters
EBIT: SEK 18.9B; latest annual
Shares: 1.60B
Total debt: SEK 77.5B
Cash: SEK 20.9B
Net debt: SEK 56.6B; debt − cash

annual report FY2025 · period ended 2025-11-30 · filed 2025-11-30 · sec.gov

Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for HMRZF

Loading history...

H&M HENNES & MAURITZ AB trades at $18.56. We are not reading assumptions out of that price: financials are filed in SEK; our prices are in USD, so these methods need a conversion we do not yet publish.

The filing behind these numbers

Valuation tool: build your own HMRZF range

Daily Price — HMRZF

Your range0 of 7 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on HMRZF

Compare with peers

Explore

Valuation tool: build your own HMRZF range

Daily Price — HMRZF

Your range0 of 7 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on HMRZF

Compare with peers

Explore